Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia

文献类型： 外文期刊

第一作者： Ma, Yan-ping

作者： Ma, Yan-ping;Ke, Hao;Liang, Zhi-ling;Ma, Jiang-yao;Hao, Le;Liu, Zhen-xing

作者机构：

关键词： Tilapia streptococcus agalactiae;Cationic-PLGA microspheres;Oral vaccine;Immunogenicity analysis

期刊名称：FISH & SHELLFISH IMMUNOLOGY （ 影响因子：4.581； 五年影响因子：4.851 ）

ISSN：

年卷期：

页码：

收录情况： SCI

摘要： Streptococcus agalactiae (S. agalactiae) is an important fish pathogen, which has received more attention in the past decade due to the increasing economic losses in the tilapia industry worldwide. As existing effective vaccines of S. agalactiae in fish have obvious disadvantage, to select immunoprotective antigens and package materials would undoubtedly contribute to the development of novel oral vaccines. In the present study, surface immunogenic protein (sip) was selected from the S. agalactiae serovar I a genomes as immunogenic protein in DNA vaccine form with cationic chitosan and biodegradable and biocompatible PLGA. The pcSip plasmid in cationic-PLGA was successfully expressed in tissues of immunized tilapia and the immunogenicity was assessed in tilapia challenge model. A significant increase was observed in the cytokine levels of IL-1 beta, TNF-alpha, CC1, CC2 in spleen and kidney tissues. Furthermore, immunized tilapia conferred different levels of protection against challenge with a lethal dose of highly virulent serovar I a S. agalactiae. Our results indicated that the pcSip plasmid in cationic-PLGA induced high level of antibodies and protection against S. agalactiae infection, could be effective oral DNA vaccine candidates. (C) 2017 Elsevier Ltd. All rights reserved.

分类号： S9

  • 相关文献

[1]LuxS/AI-2 in Streptococcus agalactiae reveals a key role in acid tolerance and virulence. Ma, Yanping,Hao, Le,Ke, Hao,Liang, Zhiling,Ma, Jiangyao,Liu, Zhenxing,Li, Yugu. 2017

[2]Oral administration of Anabaena-expressed VP28 for both drug and food against white spot syndrome virus in shrimp. Jia, Xiao-Hui,Shi, Ding-Ji,Zhuang, Min-Min,Wang, Xiang,Jia, Rui,Zhang, Zheng-Yang,Sun, Yi-Hua,Qian, Wen-Yi,He, Pei-Min,Zhang, Chun-Li,Peng, Guo-Hong,Shi, Ding-Ji,Huang, Jie.

[3]Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai, Lei,Wang, Xijun,Ge, Jinying,Wen, Zhiyuan,Chen, Weiye,Qin, Lide,Bu, Zhigao,Feng, Na,Xia, Xianzhu.

[4]Isolation and analysis of the vaccine potential of an attenuated Edwardsiella tarda strain. Sun, Yun,Liu, Chun-sheng,Sun, Li,Sun, Yun,Liu, Chun-sheng. 2010

[5]Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Shuai, Lei,Wang, Xijun,Wen, Zhiyuan,Ge, Jinying,Wang, Jinliang,Zhao, Dandan,Bu, Zhigao.

[6]Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Yang YanMei,Fang RongXiang,Chen XiaoYing,Yang YanMei,Fang RongXiang,Chen XiaoYing,Yang YanMei,Li Xia,Yang Hui,Qian Yuan,Zhang You. 2011

作者其他论文 更多>>

微信小程序